Local view for "http://purl.org/linkedpolitics/eu/plenary/2005-12-01-Speech-4-112"
Predicate | Value (sorted: default) |
---|---|
rdf:type | |
dcterms:Date | |
dcterms:Is Part Of | |
dcterms:Language | |
lpv:document identification number |
"en.20051201.30.4-112"2
|
lpv:hasSubsequent | |
lpv:speaker | |
lpv:spokenAs | |
lpv:translated text |
".
Thanks to the commitment of the UK Presidency and of the European Parliament’s rapporteurs, it has been possible to reach an agreement on this regulation relating to the compulsory licensing of patents for pharmaceutical products.
This agreement enables a new balance to be found for the European Commission’s proposal which, in the context of the WTO decision, made it still more difficult for countries faced with serious public health problems to gain access to medicines.
This compromise with the Council is satisfying because the compulsory licensing system is extended to NGOs, international organisations and non-WTO members. The compromise authorises exports to countries forming part of the same regional bloc.
I regret the refusal to promote technology transfer to the countries of the South, as well as the continued ability of the Member States to prescribe additional requirements.
This legislation, which will, however, only enter into force two and a half years after the adoption of the WTO decision, proves necessary for a large number of developing countries faced with serious public health problems. I am delighted that this decision coincides with World AIDS Day."@en1
|
Named graphs describing this resource:
The resource appears as object in 2 triples